Prevention of respiratory syncytial virus disease by immunisation.
作者信息
Benzaken Tami R, Watson Conall, Drysdale Simon B
机构信息
Immunisations and vaccine preventable disease division, United Kingdom Health Security Agency (UKHSA), London, UK.
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
出版信息
Arch Dis Child Educ Pract Ed. 2025 May 16;110(3):117-120. doi: 10.1136/archdischild-2024-326964.
Abstract
摘要
相似文献
1
Prevention of respiratory syncytial virus disease by immunisation.通过免疫接种预防呼吸道合胞病毒疾病。
Arch Dis Child Educ Pract Ed. 2025 May 16;110(3):117-120. doi: 10.1136/archdischild-2024-326964.
2
Estimating the impact of Western Australia's first respiratory syncytial virus immunisation program for all infants: A mathematical modelling study.评估西澳大利亚州首个针对所有婴儿的呼吸道合胞病毒免疫计划的影响：一项数学建模研究。
Vaccine. 2025 May 22;56:127155. doi: 10.1016/j.vaccine.2025.127155. Epub 2025 May 7.
3
"We've wanted to vaccinate against it and now we can": views of respiratory syncytial virus disease and immunisation held by caregivers of Aboriginal children in Perth, Western Australia.“我们一直希望能针对它进行疫苗接种，现在我们可以了”：西澳大利亚州珀斯市原住民儿童照料者对呼吸道合胞病毒疾病及免疫接种的看法
Aust N Z J Public Health. 2025 Feb;49(1):100216. doi: 10.1016/j.anzjph.2024.100216. Epub 2025 Jan 9.
4
Respiratory syncytial virus seasonality and its implications on prevention strategies.呼吸道合胞病毒的季节性及其对预防策略的影响。
Hum Vaccin Immunother. 2018 Jan 2;14(1):234-244. doi: 10.1080/21645515.2017.1403707. Epub 2017 Dec 15.
5
Respiratory syncytial virus (RSV) infections in adults: Current trends and recommendations for prevention - a global challenge from a local perspective.成人呼吸道合胞病毒（RSV）感染：当前趋势及预防建议——从地方视角看全球挑战
Hum Vaccin Immunother. 2025 Dec;21(1):2514357. doi: 10.1080/21645515.2025.2514357. Epub 2025 Jun 18.
6
Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review.成人对呼吸道合胞病毒感染的宿主免疫反应及其对保护作用和易感性的影响：一项系统文献综述
Expert Rev Clin Immunol. 2025 Jun;21(6):745-760. doi: 10.1080/1744666X.2025.2494658. Epub 2025 May 2.
7
Hot topics in the prevention of respiratory syncytial virus disease.呼吸道合胞病毒病预防的热点问题。
Expert Rev Vaccines. 2011 Mar;10(3):291-3. doi: 10.1586/erv.11.13.
8
Respiratory syncytial virus immunisation overview.呼吸道合胞病毒免疫概述。
J Paediatr Child Health. 2020 Dec;56(12):1865-1867. doi: 10.1111/jpc.15232. Epub 2020 Oct 22.
9
Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis.孕期 B 群链球菌和呼吸道合胞病毒免疫接种：全景分析。
Lancet Infect Dis. 2017 Jul;17(7):e223-e234. doi: 10.1016/S1473-3099(17)30232-3. Epub 2017 Apr 19.
10
Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study.呼吸道合胞病毒的季节性和低收入及中等收入国家婴儿被动免疫预防策略规划：建模研究。
Lancet Infect Dis. 2021 Sep;21(9):1303-1312. doi: 10.1016/S1473-3099(20)30703-9. Epub 2021 May 6.
本文引用的文献
1
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.尼赛珠单抗在西班牙加利西亚为婴儿进行普遍预防对呼吸道合胞病毒住院治疗的效果和影响：一项基于人群的纵向研究的初步结果。
Lancet Infect Dis. 2024 Aug;24(8):817-828. doi: 10.1016/S1473-3099(24)00215-9. Epub 2024 Apr 30.
2
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination.保护婴儿免受呼吸道合胞病毒疾病侵害：长效单克隆抗体与母体疫苗接种的影响及成本效益比较
Lancet Reg Health Eur. 2024 Jan 8;38:100829. doi: 10.1016/j.lanepe.2023.100829. eCollection 2024 Mar.
3
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.尼赛珠单抗预防婴儿呼吸道合胞病毒住院治疗。
N Engl J Med. 2023 Dec 28;389(26):2425-2435. doi: 10.1056/NEJMoa2309189.
4
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.基于 mRNA 的 RSV 前体疫苗在老年人中的疗效和安全性。
N Engl J Med. 2023 Dec 14;389(24):2233-2244. doi: 10.1056/NEJMoa2307079.
5
Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections During Pregnancy.妊娠与呼吸道合胞病毒相关的急性呼吸道感染负担。
J Infect Dis. 2024 Mar 1;229(Supplement_1):S51-S60. doi: 10.1093/infdis/jiad449.
6
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.孕期接种二价融合前F疫苗预防婴儿呼吸道合胞病毒疾病
N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5.
7
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.一种二价呼吸道合胞病毒预融合F疫苗在老年人中的疗效和安全性
N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5.
8
Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling Study.在估算高收入国家老年人呼吸道合胞病毒住院负担时对病例未充分确诊情况进行调整：一项系统评价与建模研究
Infect Dis Ther. 2023 Apr;12(4):1137-1149. doi: 10.1007/s40121-023-00792-3. Epub 2023 Mar 20.
9
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.老年人呼吸道合胞病毒预融合F蛋白疫苗
N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604.
10
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.尼塞维单抗用于患有心脏或肺部疾病或早产的婴儿预防呼吸道合胞病毒感染的安全性
N Engl J Med. 2022 Mar 3;386(9):892-894. doi: 10.1056/NEJMc2112186.
Zotero 插件